Possibly. John's been part of the MEM journey for a long time, and it's great that he's formally tied to the business since retiring from the university. He obviously brings a host of expertise around the science and is a respected body in the industry.
But realistically he hasn't built and commercialised a biotech product, brought it to market and drummed up global sales. Yes it's a good move for MEM and it will help to legitimise the product in the eyes of other KOLs, but it's not a means to an end.
Possibly. John's been part of the MEM journey for a long time,...
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.06M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 5790554 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2706897 | 3 |
View Market Depth
| Last trade - 16.12pm 05/07/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable